SL
VCYT icon

Salomon & Ludwin’s Veracyte VCYT Stock Holding History

Salomon & Ludwin’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.6K Buy
669
+34
+5% +$1.26K ﹤0.01% 1029
2025
Q4 		$27.7K Sell
635
-1
-0.2% -$40 ﹤0.01% 657
2025
Q3 		$22.9K Buy
+636
New +$18.2K ﹤0.01% 735

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Salomon & Ludwin's VCYT Position: Q1 2026 in Review

Salomon & Ludwin increased its Veracyte (VCYT) stake by 5.4% in Q1 2026, buying an estimated $1.26K and bringing the position to 669 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1029.

Salomon & Ludwin first reported a position in VCYT in Q3 2025 and has held it in 3 quarters since. The position peaked at $27.7K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Salomon & Ludwin held 669 shares of Veracyte worth $21.6K as of Q1 2026.
  • Salomon & Ludwin bought 34 Veracyte shares in Q1 2026, an estimated $1.26K.
  • Veracyte made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #1029 holding.
  • Salomon & Ludwin first reported a position in Veracyte in Q3 2025 and has held it in 3 quarters since.
  • Salomon & Ludwin's Veracyte position peaked at $27.7K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.